{"title":"3月份的书评人","authors":"","doi":"10.1111/bju.16673","DOIUrl":null,"url":null,"abstract":"<p>Like most journals, BJUI relies on the hard work and dedication of its peer reviewers and we are grateful to them all. Each month the Editorial Team nominates peer reviewers whose reviews have stood out for their quality and timeliness and those selected as the best are highlighted on this page in recognition of their exceptional work.</p><p>Dr Hemal has done pioneering work in the field of laparoscopic urology venturing in the field since 1992 and has been associated with initial development of robotic urologic surgery since 2001 developing several techniques. His unique contribution has been in training of Fellows, residents, urologists (worldwide) in addition performing live demonstration of endourological, laparoscopic and Robotic Urologic Surgical procedures in over 350 scientific conferences all across the world for educational purposes and disseminating the knowledge, Proctoring, Mentoring and Preceptorship in Laparoscopic, Endourology and Robotic Urologic Surgery during entire career spanning over 35 years. He helped developing robotic program and Team at several centres all across the world since 2001. Dr Hemal has seven books and over 450 scientific papers in peer-reviewed journals and another 200 papers and book chapters to his credit. He has been the recipient of many academic distinctions and awards to name a few prestigious BC Roy Award, UGC Hari Om Ashram award and “Padma-Shree” by the president of India. He is also recipient of several other prestigious award such as Urologist of the Decade award, Guest Scholar of the American College of Surgeons, SIU- scholar, Fulbright scholar, and Health Hero award given by Business Journal of USA. He has also received Sushruta award by Indian, American Urology association. He has been nominated as Best Doctor of America, Top Doctor of America and Top Prostate Cancer doctor since 2008 every year till the date. He was also featured as Top Prostate Cancer doctor of USA in New York Times, USA.</p><p>Dr Usher-Smith is a GP and Associate Professor of General Practice at the University of Cambridge. Her main research interest focuses on optimising the implementation of risk-stratified medicine to promote prevention and early detection of cancer and cardiovascular disease. This includes quantitative and qualitative research covering the development and validation of risk models, evaluation of the societal, psychological, behavioural and system-level aspects associated with implementation, and conducting feasibility and pilot studies within clinical practice. Alongside research on breast cancer risk assessment and risk-stratified bowel cancer screening, she co-led the Yorkshire Kidney Screening Trial, the first study to assess the feasibility of incorporating an additional abdominal CT-scan within risk-based lung cancer screening programmes, and is currently leading a feasibility study of incorporating a newly developed PREDICT Kidney risk communication tool into clinical care for patients who have undergone surgery for newly diagnosed localised kidney cancer.</p><p>Malte W. Vetterlein, MD, FEBU, is an Assistant Professor of Urology at the University Medical Centre Hamburg-Eppendorf (UKE), Germany, where he leads the Urology Research Unit. He serves as chairman of the Trauma and Reconstructive Urology Working Party of the European Association of Urology (EAU) Young Academic Urologists (YAU), is a board member of the EAU Section of Genitourinary Reconstructive Surgeons (ESGURS), and is on the faculty of the European School of Urology (ESU). Dr Vetterlein specialises in urethral reconstruction and gender-affirming surgery for transgender women. His research focuses on urethral reconstruction techniques and improving complication reporting in urological surgery. He has authored over 150 peer-reviewed articles and several book chapters. Dr Vetterlein earned his medical degree from the University of Würzburg, Germany, and completed his urology residency at UKE. He pursued research fellowships with Dr Quoc-Dien Trinh at Brigham and Women's Hospital, Harvard Medical School, Boston, MA, and with Dr Mani Menon and Dr Firas Abdollah at the Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI.</p>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"135 3","pages":"363"},"PeriodicalIF":3.7000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bju.16673","citationCount":"0","resultStr":"{\"title\":\"March's reviewers of the month\",\"authors\":\"\",\"doi\":\"10.1111/bju.16673\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Like most journals, BJUI relies on the hard work and dedication of its peer reviewers and we are grateful to them all. Each month the Editorial Team nominates peer reviewers whose reviews have stood out for their quality and timeliness and those selected as the best are highlighted on this page in recognition of their exceptional work.</p><p>Dr Hemal has done pioneering work in the field of laparoscopic urology venturing in the field since 1992 and has been associated with initial development of robotic urologic surgery since 2001 developing several techniques. His unique contribution has been in training of Fellows, residents, urologists (worldwide) in addition performing live demonstration of endourological, laparoscopic and Robotic Urologic Surgical procedures in over 350 scientific conferences all across the world for educational purposes and disseminating the knowledge, Proctoring, Mentoring and Preceptorship in Laparoscopic, Endourology and Robotic Urologic Surgery during entire career spanning over 35 years. He helped developing robotic program and Team at several centres all across the world since 2001. Dr Hemal has seven books and over 450 scientific papers in peer-reviewed journals and another 200 papers and book chapters to his credit. He has been the recipient of many academic distinctions and awards to name a few prestigious BC Roy Award, UGC Hari Om Ashram award and “Padma-Shree” by the president of India. He is also recipient of several other prestigious award such as Urologist of the Decade award, Guest Scholar of the American College of Surgeons, SIU- scholar, Fulbright scholar, and Health Hero award given by Business Journal of USA. He has also received Sushruta award by Indian, American Urology association. He has been nominated as Best Doctor of America, Top Doctor of America and Top Prostate Cancer doctor since 2008 every year till the date. He was also featured as Top Prostate Cancer doctor of USA in New York Times, USA.</p><p>Dr Usher-Smith is a GP and Associate Professor of General Practice at the University of Cambridge. Her main research interest focuses on optimising the implementation of risk-stratified medicine to promote prevention and early detection of cancer and cardiovascular disease. This includes quantitative and qualitative research covering the development and validation of risk models, evaluation of the societal, psychological, behavioural and system-level aspects associated with implementation, and conducting feasibility and pilot studies within clinical practice. Alongside research on breast cancer risk assessment and risk-stratified bowel cancer screening, she co-led the Yorkshire Kidney Screening Trial, the first study to assess the feasibility of incorporating an additional abdominal CT-scan within risk-based lung cancer screening programmes, and is currently leading a feasibility study of incorporating a newly developed PREDICT Kidney risk communication tool into clinical care for patients who have undergone surgery for newly diagnosed localised kidney cancer.</p><p>Malte W. Vetterlein, MD, FEBU, is an Assistant Professor of Urology at the University Medical Centre Hamburg-Eppendorf (UKE), Germany, where he leads the Urology Research Unit. He serves as chairman of the Trauma and Reconstructive Urology Working Party of the European Association of Urology (EAU) Young Academic Urologists (YAU), is a board member of the EAU Section of Genitourinary Reconstructive Surgeons (ESGURS), and is on the faculty of the European School of Urology (ESU). Dr Vetterlein specialises in urethral reconstruction and gender-affirming surgery for transgender women. His research focuses on urethral reconstruction techniques and improving complication reporting in urological surgery. He has authored over 150 peer-reviewed articles and several book chapters. Dr Vetterlein earned his medical degree from the University of Würzburg, Germany, and completed his urology residency at UKE. He pursued research fellowships with Dr Quoc-Dien Trinh at Brigham and Women's Hospital, Harvard Medical School, Boston, MA, and with Dr Mani Menon and Dr Firas Abdollah at the Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI.</p>\",\"PeriodicalId\":8985,\"journal\":{\"name\":\"BJU International\",\"volume\":\"135 3\",\"pages\":\"363\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bju.16673\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BJU International\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bju.16673\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJU International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bju.16673","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
像大多数期刊一样,《北京科技大学学报》依靠同行审稿人的辛勤工作和奉献精神,我们感谢他们所有人。每个月,编辑团队都会提名评审质量和及时性突出的同行审稿人,那些被评为最佳的审稿人将在本页突出显示,以表彰他们的杰出工作。自1992年以来,Hemal博士在腹腔镜泌尿外科领域进行了开创性的工作,并自2001年以来参与了机器人泌尿外科手术的初步开发,开发了几种技术。他的独特贡献是培训研究员、住院医生、泌尿科医生(全世界),此外,他还在全球350多个科学会议上进行了腔内、腹腔镜和机器人泌尿外科手术的现场演示,以达到教育目的,并在整个35年的职业生涯中传播了腹腔镜、腔内和机器人泌尿外科手术的知识,监督、指导和指导。自2001年以来,他在世界各地的几个中心帮助开发机器人程序和团队。Hemal博士出版了7本书,在同行评议的期刊上发表了450多篇科学论文,另有200篇论文和书籍章节值得称赞。他曾获得许多学术荣誉和奖项,其中包括著名的BC Roy奖,UGC Hari Om Ashram奖和印度总统颁发的“Padma-Shree”奖。他还获得了其他几个著名奖项,如十年泌尿科医师奖、美国外科学会客座学者、SIU学者、富布赖特学者和美国商业杂志颁发的健康英雄奖。他还获得了印度、美国泌尿学协会颁发的Sushruta奖。自2008年以来,他每年都被提名为美国最佳医生,美国顶级医生和顶级前列腺癌医生。他还被美国《纽约时报》评为美国最佳前列腺癌医生。亚瑟-史密斯博士是剑桥大学全科医生和全科医学副教授。她的主要研究兴趣集中在优化风险分层医学的实施,以促进癌症和心血管疾病的预防和早期发现。这包括定量和定性研究,涵盖风险模型的开发和验证,与实施相关的社会、心理、行为和系统层面的评估,以及在临床实践中进行可行性和试点研究。除了乳腺癌风险评估和风险分层肠癌筛查研究外,她还共同领导了约克郡肾脏筛查试验,这是第一个评估在基于风险的肺癌筛查项目中纳入额外腹部ct扫描可行性的研究。目前正在领导一项可行性研究,将新开发的PREDICT肾脏风险沟通工具纳入新诊断的局部肾癌手术患者的临床护理。Malte W. Vetterlein,医学博士,FEBU,是德国汉堡-埃彭多夫大学医学中心(UKE)的泌尿学助理教授,在那里他领导泌尿学研究部门。他是欧洲泌尿外科协会(EAU)青年学术泌尿外科医师(YAU)创伤和重建泌尿外科工作组的主席,是泌尿生殖外科重建外科(ESGURS)的EAU部门的董事会成员,也是欧洲泌尿外科学院(ESU)的教员。Vetterlein博士擅长为跨性别女性进行尿道重建和性别确认手术。他的研究主要集中在尿道重建技术和改善泌尿外科并发症的报告。他撰写了150多篇同行评审的文章和几本书的章节。Vetterlein博士在德国维尔茨堡大学获得医学学位,并在英国大学完成了泌尿外科住院医师实习期。他曾与马萨诸塞州波士顿哈佛医学院布里格姆妇女医院的quocc - dien Trinh博士以及密歇根州底特律亨利福特医院Vattikuti泌尿学研究所的Mani Menon博士和Firas abdullah博士共同获得研究奖学金。
Like most journals, BJUI relies on the hard work and dedication of its peer reviewers and we are grateful to them all. Each month the Editorial Team nominates peer reviewers whose reviews have stood out for their quality and timeliness and those selected as the best are highlighted on this page in recognition of their exceptional work.
Dr Hemal has done pioneering work in the field of laparoscopic urology venturing in the field since 1992 and has been associated with initial development of robotic urologic surgery since 2001 developing several techniques. His unique contribution has been in training of Fellows, residents, urologists (worldwide) in addition performing live demonstration of endourological, laparoscopic and Robotic Urologic Surgical procedures in over 350 scientific conferences all across the world for educational purposes and disseminating the knowledge, Proctoring, Mentoring and Preceptorship in Laparoscopic, Endourology and Robotic Urologic Surgery during entire career spanning over 35 years. He helped developing robotic program and Team at several centres all across the world since 2001. Dr Hemal has seven books and over 450 scientific papers in peer-reviewed journals and another 200 papers and book chapters to his credit. He has been the recipient of many academic distinctions and awards to name a few prestigious BC Roy Award, UGC Hari Om Ashram award and “Padma-Shree” by the president of India. He is also recipient of several other prestigious award such as Urologist of the Decade award, Guest Scholar of the American College of Surgeons, SIU- scholar, Fulbright scholar, and Health Hero award given by Business Journal of USA. He has also received Sushruta award by Indian, American Urology association. He has been nominated as Best Doctor of America, Top Doctor of America and Top Prostate Cancer doctor since 2008 every year till the date. He was also featured as Top Prostate Cancer doctor of USA in New York Times, USA.
Dr Usher-Smith is a GP and Associate Professor of General Practice at the University of Cambridge. Her main research interest focuses on optimising the implementation of risk-stratified medicine to promote prevention and early detection of cancer and cardiovascular disease. This includes quantitative and qualitative research covering the development and validation of risk models, evaluation of the societal, psychological, behavioural and system-level aspects associated with implementation, and conducting feasibility and pilot studies within clinical practice. Alongside research on breast cancer risk assessment and risk-stratified bowel cancer screening, she co-led the Yorkshire Kidney Screening Trial, the first study to assess the feasibility of incorporating an additional abdominal CT-scan within risk-based lung cancer screening programmes, and is currently leading a feasibility study of incorporating a newly developed PREDICT Kidney risk communication tool into clinical care for patients who have undergone surgery for newly diagnosed localised kidney cancer.
Malte W. Vetterlein, MD, FEBU, is an Assistant Professor of Urology at the University Medical Centre Hamburg-Eppendorf (UKE), Germany, where he leads the Urology Research Unit. He serves as chairman of the Trauma and Reconstructive Urology Working Party of the European Association of Urology (EAU) Young Academic Urologists (YAU), is a board member of the EAU Section of Genitourinary Reconstructive Surgeons (ESGURS), and is on the faculty of the European School of Urology (ESU). Dr Vetterlein specialises in urethral reconstruction and gender-affirming surgery for transgender women. His research focuses on urethral reconstruction techniques and improving complication reporting in urological surgery. He has authored over 150 peer-reviewed articles and several book chapters. Dr Vetterlein earned his medical degree from the University of Würzburg, Germany, and completed his urology residency at UKE. He pursued research fellowships with Dr Quoc-Dien Trinh at Brigham and Women's Hospital, Harvard Medical School, Boston, MA, and with Dr Mani Menon and Dr Firas Abdollah at the Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI.
期刊介绍:
BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.